Cargando…
Anti-malarial ozonides OZ439 and OZ609 tested at clinically relevant compound exposure parameters in a novel ring-stage survival assay
BACKGROUND: Drug efficacy against kelch 13 mutant malaria parasites can be determined in vitro with the ring-stage survival assay (RSA). The conventional assay protocol reflects the exposure profile of dihydroartemisinin. METHODS: Taking into account that other anti-malarial peroxides, such as the s...
Autores principales: | Walz, Annabelle, Leroy, Didier, Andenmatten, Nicole, Mäser, Pascal, Wittlin, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918666/ https://www.ncbi.nlm.nih.gov/pubmed/31849323 http://dx.doi.org/10.1186/s12936-019-3056-8 |
Ejemplares similares
-
Monoclonal Antibodies That Recognize the Alkylation
Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)
por: Jourdan, Joëlle, et al.
Publicado: (2015) -
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
por: Moehrle, Joerg J, et al.
Publicado: (2013) -
Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513
por: Coulter, Don W., et al.
Publicado: (2016) -
Encapsulation of OZ439 into Nanoparticles for Supersaturated
Drug Release in Oral Malaria Therapy
por: Lu, Hoang D., et al.
Publicado: (2018) -
The Wizard of Oz /
por: Baum, L. Frank (Lyman Frank), 1856-1919
Publicado: (1982)